Women’s health experts have issued a warning about the limitations of the first-of-its-kind endometriosis treatment pill, ...

A new combination pill has been given the green light by the National Institute for Health and Care Excellence (Nice) to ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

A new pill designed to transform the treatment of endometriosis has been approved for use on the NHS. The combination drug ...

Hoorah for some positive women's health news! A new endometriosis pill has been made available on the NHS in England, in what ...

A transformational new pill for treating endometriosis has been approved for use on the NHS across England. The new tablet, ...

We believe quality journalism should be available to everyone, paid for by those who can afford it. A first-of-its-kind pill for endometriosis has been approved for NHS use, offering hope for people ...

The first-of-its-kind endometriosis pill provides hope for 1.5 million people in the UK affected by the condition ...

The new drug, called relugolix-estradiol-norethisterone, is a combination pill that blocks specific hormones that contribute ...

The treatment, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), works by blocking specific hormones that contribute to endometriosis, while also ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...